HIV load testing with small samples of whole blood

Journal of Clinical Microbiology

Volumn 48, Issue 8, 2010, Pages 2786-2792

  Steinmetzer, Katrin ^a   Seidel, Thomas ^b   Stallmach, Andreas ^b   Ermantraut, Eugen ^a  

^a CLONDIAG GmbH   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROCEDURES; VIROLOGY;

BLOOD; HIV INFECTIONS; HUMANS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77955434908     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02276-09     Document Type: Article

References (44)

1. Alvarez-Munoz, M. T., S. Zaragoza-Rodriguez, O. Rojas-Montes, G. Palacios-Saucedo, G. Vazquez-Rosales, A. Gomez-Delgado, J. Torres, and O. Munoz. 2005. High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Arch. Med. Res. 36:382-386.
2. Reference deleted.
3. Ayele, W., R. Schuurman, T. Messele, W. Dorigo-Zetsma, Y. Mengistu, J. Goudsmit, W. A. Paxton, M. P. de Baar, and G. Pollakis. 2007. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J. Clin. Microbiol. 45:891-896.
4. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. M. Comeau, S. A. Cassol, R. Dickover, J. B. Jackson, J. Pitt, J. L. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. A. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
5. Bruisten, S., B. van Gemen, M. Koppelman, M. Rasch, D. van Strijp, R. Schukkink, R. Beyer, H. Weigel, P. Lens, and H. Huisman. 1993. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res. Hum. Retrovir. 9:259-265.
6. Bruisten, S. M., M. H. Koppelman, M. T. Roos, A. E. Loeliger, P. Reiss, C. A. Boucher, and H. G. Huisman. 1993. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS 7(Suppl. 2):S15-S20.
7. Carr, J. M., H. Hocking, P. Li, and C. J. Burrell. 1999. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265:319-329. (Pubitemid 30022226)
8. Cena, M., N. Schwachsa, M. N. Garcia, M. M. Avila, and R. D. Rabinovic. 2004. Determination of HIV-1 p24 antigen associated with erythrocytes: potential uses. International Conference on AIDS, abstr. no. B11460.
9. Chun, T. W., D. C. Nickle, J. S. Justement, D. Large, A. Semerjian, M. E. Curlin, M. A. O'Shea, C. W. Hallahan, M. Daucher, D. J. Ward, S. Moir, J. I. Mullins, C. Kovacs, and A. S. Fauci. 2005. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Invest. 115:3250-3255.
10. De Cock, K. M., S. P. Crowley, Y. R. Lo, R. M. Granich, and B. G. Williams. 2009. Preventing HIV transmission with antiretrovirals. Bull. World Health Organ. 87:488A.
11. Dimitrov, D. S., R. L. Willey, H. Sato, L. J. Chang, R. Blumenthal, and M. A. Martin. 1993. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:2182-2190. (Pubitemid 23088394)
12. Fiscus, S. A., D. Brambilla, L. Grosso, J. Schock, and M. Cronin. 1998. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J. Clin. Microbiol. 36:258-260.
13. Furtado, M. R., D. S. Callaway, J. P. Phair, K. J. Kunstman, J. L. Stanton, C. A. Macken, A. S. Perelson, and S. M. Wolinsky. 1999. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340:1614-1622.
14. Garcia, M. N., M. S. dos Ramos Farías, N. Schvachsa, D. Rabinovich, and M. M. Avila. 2006. Detection of HIV-1 antigen associated to erythrocytes in patients with undetectable viral load in plasma for more than 1 year, poster P19. International Meeting of the Institute of Human Virology, Baltimore, MD. Retrovirology 3(Suppl. 1):P19.
15. Garrido, C., N. Zahonero, A. Corral, M. Arredondo, V. Soriano, and C. de Mendoza. 2009. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott Real-Time HIV load tests. J. Clin. Microbiol. 47:1031-1036.
16. Granich, R. M., C. F. Gilks, C. Dye, K. M. De Cock, and B. G. Williams. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373:48-57.
17. Gross, R., W. B. Bilker, H. M. Friedman, and B. L. Strom. 2001. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 15:2109-2117. (Pubitemid 33101818)
18. Hamers, R. L., P. W. Smit, W. Stevens, R. Schuurman, and T. F. Rinke de Wit. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir. Ther. 14:619-629.
19. Hammer, S. M., J. J. Eron, Jr., P. Reiss, R. T. Schooley, M. A. Thompson, S. Walmsley, P. Cahn, M. A. Fischl, J. M. Gatell, M. S. Hirsch, D. M. Jacobsen, J. S. Montaner, D. D. Richman, P. G. Yeni, P. A. Volberding, and AS-U.S.A. International. 2008. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-U.S.A. panel. JAMA 300:555-570.
20. Hawkins, C., and R. L. Murphy. 2009. Management of antiretroviral failure and resistance in developing countries. Curr. Opin. HIV AIDS 4:538-544.
21. He, W., S. Neil, H. Kulkarni, E. Wright, B. K. Agan, V. C. Marconi, M. J. Dolan, R. A. Weiss, and S. K. Ahuja. 2008. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 4:52-62.
22. Hess, C., T. Klimkait, L. Schlapbach, V. Del Zenero, S. Sadallah, E. Horakova, G. Balestra, V. Werder, C. Schaefer, M. Battegay, and J. A. Schifferli. 2002. Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet 359:2230-2234.
23. Holodniy, M., D. A. Katzenstein, D. M. Israelski, and T. C. Merigan. 1991. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J. Clin. Invest. 88:1755-1759.
24. Johannessen, A., C. Garrido, N. Zahonero, L. Sandvik, E. Naman, S. L. Kivuyo, M. J. Kasubi, S. G. Gundersen, J. N. Bruun, and C. de Mendoza. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981.
25. Johannessen, A., M. Troseid, and A. Calmy. 2009. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings. J. Antimicrob. Chemother. 64:1126-1129.
26. Kaiser, P., B. Joos, B. Niederost, R. Weber, H. F. Gunthard, and M. Fischer. 2007. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. J. Virol. 81:9693-9706.
27. Kupfer, B., B. Matz, M. P. Daumer, F. Roden, J. K. Rockstroh, N. Qurishi, U. Spengler, and R. Kaiser. 2007. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml. J. Med. Virol. 79:1440-1445.
28. Lee, T. H., R. R. Stromberg, J. W. Heitman, L. Sawyer, C. V. Hanson, and M. P. Busch. 1998. Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets. Transfusion 38:580-588.
29. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
30. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
31. Moir, S., A. Malaspina, Y. Li, T. W. Chun, T. Lowe, J. Adelsberger, M. Baseler, L. A. Ehler, S. Liu, R. T. Davey, Jr., J. A. Mican, and A. S. Fauci. 2000. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 192:637-646.
32. Monleau, M., C. Montavon, C. Laurent, M. Segondy, B. Montes, E. Delaporte, F. Boillot, and M. Peeters. 2009. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J. Clin. Microbiol. 47:1107-1118.
33. + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann. Intern. Med. 126:939-945.
34. Olinger, G. G., M. Saifuddin, and G. T. Spear. 2000. CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. J. Virol. 74:8550-8557. (Pubitemid 30666706)
35. Pasternak, A. O., K. W. Adema, M. Bakker, S. Jurriaans, B. Berkhout, M. Cornelissen, and V. V. Lukashov. 2008. Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J. Clin. Microbiol. 46:2206-2211.
36. Saah, A. J., and D. R. Hoover. 1997. "Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings. Ann. Intern. Med. 126:91-94.
37. Semple, M., C. Loveday, I. Weller, and R. Tedder. 1991. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J. Med. Virol. 35:38-45.
38. Stevens, W., L. Erasmus, M. Moloi, T. Taleng, and S. Sarang. 2008. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants. J. Clin. Microbiol. 46:3941-3945.
39. Tobler, L. H., J. Dockter, S. L. Stramer, S. H. Kleinman, D. Todd, C. Giachetti, and M. P. Busch. 2002. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood. Transfusion 42:1525-1527.
40. Torre, D., and A. Pugliese. 2008. Platelets and HIV-1 infection: old and new aspects. Curr. HIV Res. 6:411-418.
41. Waters, L., A. Kambugu, H. Tibenderana, D. Meya, L. John, S. Mandalia, M. Nabankema, I. Namugga, T. C. Quinn, B. Gazzard, S. J. Reynolds, and M. Nelson. 2007. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J. Acquir. Immune Defic. Syndr. 46:590-593.
42. World Health Organization. 2006. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.
43. World Health Organization, Joint United Nations Programme on HIV/AIDS, and United Nations International Children's Emergency Fund. 2009. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/tuapr-2009-en.pdf.
44. + monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76:707-716.